Ceribell (CBLL) Debt Ratio (2024 - 2026)

Ceribell (CBLL) reported Debt Ratio of 0.11 for Q1 2026, up 21.7% on a YoY basis from 0.09 in Q1 2025, and up 10.54% quarter-over-quarter from 0.1 in Q4 2025.

Ceribell (CBLL) Debt Ratio (2024 - 2026) Analysis & Trends

Ceribell has reported Debt Ratio for 3 years, with the latest figure at 0.11 in Q1 2026.

  • For the quarter ending Q1 2026, Debt Ratio rose 21.7% year-over-year to 0.11; the trailing twelve-month figure through Mar 2026 stood at 0.11 (up 21.7% YoY), and the FY2025 full-year result was 0.1, up 16.61% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.11, up from 0.1 in the prior quarter.
  • The five-year high for Debt Ratio was 0.41 in Q3 2024, with the low at 0.09 in Q4 2024.
  • Historically, Debt Ratio has averaged 0.14 across 3 years, with a median of 0.1 in 2025.
  • Annual changes were most pronounced in 2025 — Debt Ratio tumbled 76.11% — and 2026, when it rose 21.7%.
  • Ceribell's Debt Ratio stood at 0.09 in 2024, then climbed by 16.61% to 0.1 in 2025, then grew by 10.54% to 0.11 in 2026.
  • The last three Debt Ratio figures came in at 0.11 (Q1 2026), 0.1 (Q4 2025), and 0.1 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 0.31
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 0.32
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 0.31
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 0.04
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 0.27
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 0.18
10 Ceribell 695.83 Mn 554.65 Mn 23.12 Mn 0.11

Historic Data

Download Data
DateValue
Mar 31, 2026 0.11
Dec 31, 2025 0.10
Sep 30, 2025 0.10
Jun 30, 2025 0.09
Mar 31, 2025 0.09
Dec 31, 2024 0.09
Sep 30, 2024 0.41